Go to deals
Consumer & Retail | Food & Beverage | Private Equity

Léa Compagnie Biodiversité has acquired a minority stake in Soup'Idéale

Léa Compagnie Biodiversité, a producer of organic and natural food products, has acquired a 35% stake in Soup'Idéale. Financial details have not been disclosed.

Founded in 1993, Léa Compagnie Biodiversité is an independent, family owned company created by Charles and Catherine Kloboukoff. It develops, manufactures and distributes organic and natural food, health and nutrition products, cosmetics and household products to retail chains, supermarkets and specialized stores (pharmacies and organic health food stores). In 2018, the company reported revenues of US$454 million and US$80 million in EBIT. Léa Compagnie Biodiversité, with 1,320 employees, offers 4,000 references through 21 brands and has 16 production sites.

Soup'Idéale specializes in soup manufacturing and distributes its products mainly to three market segments: mass retail, hospitals and hard discount retail. In 2018, the company generated revenues of US$18 million and has approximately 50 employees. Soup'Idéale is the first soup producer to feature Tetra Pack® technology, which preserves the organoleptic properties of vegetables and whose packaging is recyclable.

Oaklins' team in France advised the buyer in this transaction.

Parties

Talk to the deal team

 Philippe  Hermant

Philippe Hermant

Senior Advisor
Paris, France
Oaklins France
 Éric  Félix-Faure

Éric Félix-Faure

Managing Partner
Paris, France
Oaklins France

Related deals

MBO of Norway’s leading service and technology provider for food production
Food & Beverage

MBO of Norway’s leading service and technology provider for food production

Tine and Nortura have sold Skala Gruppen AS to the management team.

Learn more
White Lab has acquired Testing
Private Equity | Business Support Services

White Lab has acquired Testing

White Lab Srl. has acquired Testing Srl.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more